share_log

CNS Pharmaceuticals | 10-K/A: Annual report (Amendment)

SEC ·  May 2, 2023 05:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more